Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardioprotective Drugs in Type 1 Diabetic Children
NCT03660293Completed
- Sponsor
- Tanta University
- Start
- Apr 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of atorvastatin, captopril and levocarnitine in diabetic cardiomyopathy (DCM) (5 arms), sponsored by Tanta University. Primary endpoint: Cardiac changes induced by cardio-protective agents at 4 months. Started Apr 2017; status: completed.
02
Drugs
atorvastatincaptoprillevocarnitine
03
Conditions
diabetic cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT03660293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03660293.